Erector Spinae Plane Block Catheters and Intrathecal Morphine for Hepatic Resection

Description

To determine whether the addition of erector spinae plane (ESP) catheters to existing multimodal analgesic regimen with intrathecal morphine provides superior postoperative analgesia in patients undergoing hepatic resection compared with patients not receiving ESP catheters.

Conditions

Hepatic Resection, Acute Pain, Anesthesia, Anesthesia, Local

Study Overview

Study Details

Study overview

To determine whether the addition of erector spinae plane (ESP) catheters to existing multimodal analgesic regimen with intrathecal morphine provides superior postoperative analgesia in patients undergoing hepatic resection compared with patients not receiving ESP catheters.

Erector Spinae Plane Block Catheters: The Role in Acute Postoperative Pain After Hepatic Resection With Intrathecal Morphine

Erector Spinae Plane Block Catheters and Intrathecal Morphine for Hepatic Resection

Condition
Hepatic Resection
Intervention / Treatment

-

Contacts and Locations

San Diego

University of California, San Diego, San Diego, California, United States, 92103

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * undergoing hepatic resection
  • * Admitting service requests APS consult
  • * \>18 years old and able to provide consent
  • * pregnancy
  • * incarceration
  • * inability to communicate with the investigators and hospital staff
  • * severe hepatic disease
  • * chronic high-dose opioid use (defined as daily use for more than 4 weeks prior to surgery of at least the equivalent of 20 mg oxycodone);
  • * BMI \> 40 kg/m2
  • * allergy to study medications (lidocaine, ropivacaine)

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of California, San Diego,

Engy T Said, MD, PRINCIPAL_INVESTIGATOR, University of California, San Diego

Study Record Dates

2023-05-01